Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Scandinavian Journal of Pain
|
August 30, 2017
A randomized study to evaluate the analgesic efficacy of a single dose of the TRPV1 antagonist mavatrep in patients with osteoarthritis
Arthur J Mayorga, Christopher M Flores, Jeremiah J Trudeau, et al.
Neurology. Clinical Practice
|
April 8, 2024
Immediate Reactions to Alzheimer Biomarker Disclosure in Cognitively Unimpaired Individuals in a Global Truncated Randomized Trial
Joshua D Grill, Rema Raman, Karin Ernstrom, et al.
Journal of Alzheimer'S Disease : JAD
|
September 25, 2015
Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study
Samantha C Burnham, Nandini Raghavan, William Wilson, et al.
JAMA Neurology
|
January 19, 2021
Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical Trial
Reisa Sperling, David Henley, Paul S Aisen, et al.
Nature Medicine
|
March 5, 2026
The TREM2 agonistic antibody AL002 in early Alzheimer's disease: a phase 2 randomized trial
Catherine J Mummery, Arthur J Mayorga, Adam Simmons, et al.
Therapeutic Innovation & Regulatory Science
|
September 22, 2018
Coalition Against Major Diseases: Precompetitive Collaborations and Regulatory Paths to Accelerating Drug Development for Neurodegenerative Diseases
Diane Stephenson, Enrique Aviles, Lisa J Bain, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 15, 2018
The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable
David S Knopman, Samantha Budd Haeberlein, Maria C Carrillo, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Scandinavian Journal of Pain
|
August 30, 2017
A randomized study to evaluate the analgesic efficacy of a single dose of the TRPV1 antagonist mavatrep in patients with osteoarthritis
Arthur J Mayorga, Christopher M Flores, Jeremiah J Trudeau, et al.
Neurology. Clinical Practice
|
April 8, 2024
Immediate Reactions to Alzheimer Biomarker Disclosure in Cognitively Unimpaired Individuals in a Global Truncated Randomized Trial
Joshua D Grill, Rema Raman, Karin Ernstrom, et al.
Journal of Alzheimer'S Disease : JAD
|
September 25, 2015
Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study
Samantha C Burnham, Nandini Raghavan, William Wilson, et al.
JAMA Neurology
|
January 19, 2021
Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical Trial
Reisa Sperling, David Henley, Paul S Aisen, et al.
Nature Medicine
|
March 5, 2026
The TREM2 agonistic antibody AL002 in early Alzheimer's disease: a phase 2 randomized trial
Catherine J Mummery, Arthur J Mayorga, Adam Simmons, et al.
Therapeutic Innovation & Regulatory Science
|
September 22, 2018
Coalition Against Major Diseases: Precompetitive Collaborations and Regulatory Paths to Accelerating Drug Development for Neurodegenerative Diseases
Diane Stephenson, Enrique Aviles, Lisa J Bain, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
April 15, 2018
The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable
David S Knopman, Samantha Budd Haeberlein, Maria C Carrillo, et al.
Page
of 2